Learn More
High-dose therapy plus autologous stem cell transplantation (ASCT) is considered the standard of care for the frontline treatment in younger patients with multiple myeloma (NDMM). The achievement of(More)
Minimal residual disease (MRD) quantification is widely used for therapeutic stratification in pediatric acute lymphoblastic leukemia (ALL). A robust, reproducible, sensitivity of at least 0.01% has(More)